Anúncio
Anúncio

AGL

AGL logo

agilon health, inc.

0.90
USD
Patrocinado
+0.12
+15.39%
08 de jan., 16:00 UTC -5
Encerrado
exchange

Pós-Mercado

0.89

-0.02
-1.66%

Relatórios de Lucros AGL

Rácio de surpresa positiva

AGL separação 5 de 19 últimas estimativas.

26%

Próximo Relatório

Data do Próximo Relatório
23 de fev. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$1.48B
/
-$0.27
Mudanças implicadas de Q3 25 (Revenue/ EPS)
+2.81%
/
--
Mudanças implicadas de Q4 24 (Revenue/ EPS)
-3.08%
/
+3.85%

agilon health, inc. earnings per share and revenue

On 04 de nov. de 2025, AGL reported earnings of -0.27 USD per share (EPS) for Q3 25, missing the estimate of -0.15 USD, resulting in a -68.86% surprise. Revenue reached 1.44 bilhão, compared to an expected 1.44 bilhão, with a -0.16% difference. The market reacted with a +4.05% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 17 analistas forecast an EPS of -0.27 USD, with revenue projected to reach 1.48 bilhão USD, implying an aumentar of 0.00% EPS, and aumentar of 2.81% in Revenue from the last quarter.
FAQ
For Q3 2025, agilon health, inc. reported EPS of -$0.27, missing estimates by -68.86%, and revenue of $1.44B, -0.16% below expectations.
The stock price moved up 4.05%, changed from $0.72 before the earnings release to $0.75 the day after.
The next earning report is scheduled for 23 de fev. de 2026.
Based on 17 analistas, agilon health, inc. is expected to report EPS of -$0.27 and revenue of $1.48B for Q4 2025.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio